“A Study of LY3154885 in Healthy Participants”
The main purpose of this study is to learn more about the safety and side effects of LY3154885 when given by mouth to healthy participants. The study will have up to four parts. Each participant will enroll in only one part. The study will last up to 70 days for each participant, including screening and follow-up.
Drug - LY3154885 - Capsule
Drug - Placebo - Capsule
Drug - Itraconazole
Drug - LY3154885 - Tablet
Single- and Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3154885 in Healthy Subjects